When: 200 SMA at $87.27 holds, MACD histogram contracting, price closing above $87.50

Then: Add back half the trimmed size

When: Pullback to $83-84 zone, RSI <30, bullish divergence on daily chart

Then: Scale into full benchmark weight

When: Confirmed close below $87.27 (200 SMA) with volume >7M shares

Then: Exit residual entirely; wait for $84.50 structural floor defense before re-engaging

When: Confirmed weekly close below $85.85 with volume >5M

Then: Downgrade to Sell; reassess at $84.50 spring-low retest

SELL - Support trader's plan of 25 to 30 percent trim with 86.50 trailing stop, against both aggressive 50 percent plus puts and neutral hold-and-wait

• Price at 87.02 is below 10 EMA at 88.11, below 50 SMA at 90.96, and sitting on the 200 SMA at 87.27 - stacked bearish alignment with one final structural support level being tested
• MACD negative at minus 1.16 with histogram at minus 0.29 and expanding, indicating bearish momentum accelerating rather than stabilizing
• RSI at 36.93 is approaching but has not yet hit oversold, meaning no capitulation signal and no confirmed bottom
• VWMA has declined from 92.30 to 88.90, confirming volume-weighted selling with sellers in control rather than opportunistic dip buyers
• Trim 25 to 30 percent into resistance zone between 89 and 90.50, hold residual 70 to 75 percent with trailing stop at 86.50
• Trailing stop at 86.50 limits realized loss on held portion to roughly 4 percent from current levels - a bounded, definable risk
• Cap any new capital deployment at 2 to 3 percent of portfolio, gated on confirmed multi-factor reversal signal
• CL has 0.32 beta, 3.46 billion in trailing twelve month FCF, 60.4 percent gross margin, and 16.4 percent FCF margin - not characteristics of a stock that typically gaps down 10 percent on single earnings print
• Q3 earnings catalyst on October 23 is binary with real FX translation risk from 45 percent emerging market revenue exposure under hawkish Fed
• 919 million dollar impairment in Q4 2025 followed by 1 billion plus sale narrative creates credibility gap addressed through position sizing discipline
• Recyclability litigation heading toward trial is materially different from discovery - material category-level risk
• In risk-off regime, marginal allocator rotates from cyclicals into defensives within equity allocation, not from defensives to Treasuries - CL competes with growth cyclicals and high-multiple tech for defensive equity bucket

→ vs aggressive: 50 percent trim plus puts is doubling down on directional risk - it layers a short equity position with short optionality through derivatives, and when CL mean-reverts sharply from deeply oversold condition in a 0.32 beta name, those put hedges decay violently while residual equity remains exposed

→ vs aggressive: Absolute yield comparison versus Treasuries is a red herring - CL competes with growth cyclicals and high-multiple tech for defensive equity allocation, not with fixed income, and on that relative basis remains attractive even at 21 times forward earnings

→ vs aggressive: Aggressive analyst treating CL as competing directly with Treasuries ignores how institutional asset allocators actually behave in risk-off - flows show rotation from cyclicals into defensives within equity, not out of defensives into bonds

→ vs neutral: Framing of 'mixed signals, hold and wait' is fundamentally incompatible with the technical setup - price sitting on 200 SMA with stacked bearish alignment is not a mixed picture, and waiting for 200 SMA to break before acting means reacting at precisely the wrong time

→ vs neutral: If 86.50 gives way with volume, there will be no measured re-entry at 84 to 85 - instead expect gap lower that prints through intended entry zone and forces chasing or freezing while position bleeds

→ vs neutral: The neutral analyst's 'mixed signals, hold and wait' provides false comfort while leaving capital fully exposed to stacked bearish technical, binary earnings catalyst on October 23, and unresolved recyclability litigation heading to trial

SELL with refinement—trim 40% into resistance, widen trailing stop to 85.85, add staged Q3 catalyst protocol, redeploy freed capital away from pro-cyclical defensives into short-duration credit or dollar-strength beneficiaries

• Technical setup is bearish: stacked below all three major moving averages, MACD histogram expanding downside, RSI at 36.93 trending lower without bullish divergence, VWMA confirming volume-weighted selling pressure
• Macro backdrop hostile with 45% emerging market revenue exposure into hawkish Fed environment
• Credibility gap on divestiture is legitimate concern
• 0.32 beta name with $3.46 billion trailing free cash flow, 60.4% gross margins, 25 consecutive years of dividend increases
• 25-30% trim too small given risk asymmetry; 50% plus puts over-engineered and creates concentration risk on derivatives that decay in low-vol environment
• Current trailing stop at 86.50 with ATR at $1.75 provides only 52 cents of cushion—one average true range move triggers stop automatically
• Proposed widening trailing stop to 85.85 gives roughly one ATR of cushion and aligns with lower Bollinger band zone
• 4% stop loss bound only works on paper; actual total losses could reach 6-8% if stock flushes to 83-84 plus realized losses on trimmed portion
• Put options structurally expensive for 0.32 beta name due to elevated implied volatility relative to realized volatility
• Re-entry at 83-84 only attractive with confirmed capitulation signal (RSI below 30 with bullish divergence); without confirmation, flush is evidence thesis is working and trailing stop should be honored
• Freed capital from trim should not sit in cash; rotate from pro-cyclical defensives into higher-quality short-duration credit or positions benefiting from dollar strength

→ vs aggressive: High conviction bearish view does not equal rational position sizing—conflating directional view with concentrated derivatives exposure; 50% trim plus puts solves for wrong problem on low-beta name with strong fundamentals and 25 years of dividend growth

→ vs aggressive: Flush to 83-84 scenario requires multiple things going wrong simultaneously (FX miss, conservative guidance, broad risk-off continuation); probability-weighted loss on aggressive trim plus puts exceeds probability-weighted loss on balanced approach

→ vs aggressive: Put premiums are structurally elevated for low-beta names because options market makers know traders reach for protection; buying expensive hedge against low-probability tail outcome with poor risk-adjusted math

→ vs conservative: Trailing stop at 86.50 when ATR is 1.75 is false precision that gets mechanically stopped out by single bad session, headline gap, or pre-earnings wobble before re-entry conditions can be evaluated

→ vs conservative: 4% stop loss bound on held portion only works if stop executes cleanly at 86.50, which may not happen given ATR setup; combined with realized losses on trimmed portion if stock flushes, total losses reach 6-8%, not the 'sleep well' outcome being sold

→ vs conservative: Implicit assumption of binary between CL and Treasuries is false choice; dismissing defensive rotation thesis misses rotation into higher-quality short-duration credit or dollar-strength beneficiaries